About Altacor Pharma
Altacor Pharma is a Healthcare company based in Cambridge (United Kingdom) founded in 2006, and was acquired by Fidia Farma in September 2025. Specialty ophthalmology company developing a portfolio of products in the fields of dry eye, glaucoma and ocular infection. Altacor Pharma has raised $3.06 million across 2 funding rounds from investors including Fidia Farma, Enterprise Ventures and Clive Austin. Altacor Pharma offers products and services including Clinitas Drops, Clinitas Gel, BioLon, and Clinitas Antibacterial Eye Compress. Its focus areas include Life Sciences, Ophthalmology, Drugs and Diversified. Its legal entity is ALTACOR LIMITED.
Company details
Altacor develops ophthalmic products for dry-eye, glaucoma, glaucoma surgery and ocular surgery. Products include clinitas and clinitas GEL, prescription products for the treatment of moderate dry eye; Clinitas Range, for treating major causes of dry eye; Blepharitis Range loosens and removes Meibomian secretions; and Ocular supplements like EyeBar, a chocolate bar containing AREDS2 formula for the maintenance of healthy vision. The companys RD pipeline covers products for eye surgery and glaucoma. The company was acquired by Esperante in 2014.
- Headquarters Cambridge, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website altacor-pharma.com
- Social LinkedIn X Facebook YouTube
- Acquired by Esperante (Jul 2014)
- Legal Name Altacor Limited
- Date of Incorporation 12 Apr, 2005
- Jurisdiction WINDSOR, BERKSHIRE, ENGLAND
- Total Equity Funding$3.06M (USD)
in 2 rounds
- Latest Funding Round$3.06M (USD), Series A
Feb 2011
- InvestorsFidia Farma
& 4 more
- Acquired by
Products & Services of Altacor Pharma
Altacor Pharma offers a comprehensive portfolio of products and services, including Clinitas Drops, Clinitas Gel, BioLon, and Clinitas Antibacterial Eye Compress.
Provides relief for dry eye conditions through lubricating drops.
Offers hydration for severe dry eye symptoms.
Used as viscoelastic device in ophthalmic surgery procedures.
Helps alleviate symptoms of blepharitis and eye irritation.
Apps and channels of Altacor Pharma
its YouTube channel Altacor has 35 subscribers and 10 videos.
Videos from Altacor Pharma
The most watched videos on Altacor Pharma's YouTube channel, Altacor (35 subscribers). Click a video to play it here.
More on Altacor.
Funding Insights of Altacor Pharma
Altacor Pharma has successfully raised a total of $3.06M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.06 million completed in February 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.06M
- Total Rounds 2
- Last Round Series A — $3.06M
- Investors Count 4
All 2 funding rounds of Altacor Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2011 | $3.06M | Series A | – | Clive Austin | |
| Jun 2010 | Seed | – | Esperante |
5 investors in total: 4 institutional and 1 angel.
Investors in Altacor Pharma
Altacor Pharma has secured backing from 5 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Fidia Farma, Enterprise Ventures and Clive Austin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early and Growth stage Venture Debt firm that does debt investments in the UK | 1982 | evgroup.uk.com | Preston, United Kingdom | |
Tax-efficient investment opportunities are provided by ProVen for retail investors. | provenvcts.co.uk | London, United Kingdom | ||
| esperanteventures.com | ||||
CA Clive Austin | Angel investor focusing on Indian startups, experienced in tech and innovation. | unknown_fa820adbca5942bfb | ||
Proprietary hyaluronic acid treatments and derivatives are developed. | 1946 | fidiapharma.com | Abano Terme, Italy |
Investor details for Altacor Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Altacor Pharma
5 dated milestones of Altacor Pharma across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Altacor Pharma is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $3.1M.
- Exit Acquired by Esperante.
- Exit Acquired by Fidia Farma.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Altacor Pharma
Complete news archive for Altacor Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Altacor Pharma
Altacor Pharma was founded in 2006 and raised its 1st funding round 4 years after it was founded.
Altacor Pharma is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Altacor Pharma is a funded company, having raised a total of $3.06M across 2 funding rounds to date.
Altacor develops ophthalmic products for dry-eye, glaucoma, glaucoma surgery and ocular surgery. Products include clinitas and clinitas GEL, prescription products for the treatment of moderate dry eye; Clinitas Range, for treating major causes of dry eye; Blepharitis Range loosens and removes Meibomian secretions; and Ocular supplements like EyeBar, a chocolate bar containing AREDS2 formula for the maintenance of healthy vision. The companys RD pipeline covers products for eye surgery and glaucoma. The company was acquired by Esperante in 2014.
Altacor Pharma offers Clinitas Drops, Clinitas Gel, BioLon, and Clinitas Antibacterial Eye Compress.
Altacor Pharma has 5 investors. Key investors include Fidia Farma, Enterprise Ventures, Clive Austin, ProVen, and Esperante.
Altacor Pharma operates through Altacor Limited.
Yes. Altacor Pharma was acquired by Esperante in July 2014.